Registration statement for securities of certain foreign private issuers

Revenue

v3.22.1
Revenue
12 Months Ended
Dec. 31, 2021
Revenue from contracts with customers [Abstract]  
Revenue

8.Revenue

i)Disaggregation of Revenue

    

For the Year Ended December 31,

2021

2020

2019

$’000

$’000

$’000

Value-based care

220,852

26,038

Software licensing

 

60,052

 

24,603

 

2,002

Clinical services

 

42,017

 

28,631

 

14,032

 

322,921

 

79,272

 

16,034

In January 2021, we entered into a License and Support Agreement (“License Agreement”) with TELUS. As part of the License Agreement, the Group received an upfront payment of $66.9 million in exchange for the right to use the Company’s digital healthcare platform (“Software Platform”), specified upgrades to be delivered over a 24-month period, post-contract support (“PCS”), and a right to access enhancements to the Group’s Software Platform over a period of seven years. We identified that the License Agreement included multiple performance obligations and allocated the transaction price to the separate performance obligations on a relative standalone basis. We determined the standalone selling prices based on our overall pricing objectives, taking into consideration market inputs and entity specific factors, including standalone selling prices when available. We also concluded that the upfront payment included a significant financing component. As a result, the transaction price was adjusted to account for the time value of money and interest expense will be recognized over the duration of the contract.

ii)Contract Balances

The following table provides information about receivables, contract assets and contract liabilities from contracts with customers.

    

As of December 31,

2021

2020

$’000

$’000

Trade receivables (Note 20)

8,278

4,674

Contract assets (Note 20)

 

4,484

 

2,378

Contract liabilities (Note 8 iii)

 

94,182

 

76,018

The contract assets primarily relate to the Group’s rights to consideration for work performed but subject to customer acceptance at the reporting date. There was no impact on contract assets as a result of acquisition of subsidiaries. The contract assets are transferred to receivables when the rights become unconditional. This usually occurs when the Group issues an invoice to the customer. The Group’s customers generally pay for invoices in the month following the issuance date.

iii)Transaction Price Allocated to the Remaining Performance Obligations

The following table includes revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the reporting date:

    

    

    

    

    

2026 

    

and 

2022

2023

2024

2025

beyond

Total

$’000

$’000

$’000

$’000

$’000

$’000

As of December 31, 2021

23,786

18,918

19,349

17,852

14,277

94,182

The table below shows significant changes in contract liabilities:

    

2021

    

2020

$’000

$’000

Balance on January 1

76,018

81,584

Amounts billed but not recognized

 

61,176

 

18,080

Revenue recognized

 

(43,012)

 

(23,646)

Balance on December 31

 

94,182

 

76,018

No revenue was recognized from performance obligations satisfied (or partially satisfied) in previous periods.